PUBLISHER: Grand View Research | PRODUCT CODE: 1178535
PUBLISHER: Grand View Research | PRODUCT CODE: 1178535
The global vessel sealing devices market size is expected to reach USD 2,967.0 million by 2030 and is anticipated to expand at a CAGR of 9.04% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing product developments, surgical procedures, and preference for minimally invasive surgeries are some of the key drivers of this market.
The COVID-19 pandemic resulted in several challenges such as logistical bottlenecks, low demand, decreased sales and marketing activities and reduced sales. The key impact, however, was the cancellation or postponement of elective surgeries during the pandemic. Most nations went under lockdown with the implementation of movement restrictions while academic societies and regulatory bodies recommended the postponement of elective surgical procedures.
According to Harvard Business Review, around a 4.8% GDP decline in the American economy, in the first quarter of 2020, could be attributed to deferred healthcare services, in particular delayed elective procedures. The resumption of elective surgeries is expected to lead to increased demand over the coming years.
The number of surgeries performed is a key contributor to the market growth. In the U.S. increasing prevalence of chronic diseases and an aging population, are leading to an increase in the number of surgical procedures performed every year. According to the U.S. Census Bureau, an estimated 75 million of the 328 million U.S. population, were aged 60 years and older in 2019. This implies that a significant number of American citizens are vulnerable to chronic and acute conditions, leading to an increased number of surgeries. According to Definitive Healthcare, LLC, as of 2019, there were about 9,280 active ambulatory surgery centers in the U.S. This high number also contributes to market growth.
In addition, ASCs enable large volumes of surgeries in a short period, which is expected to fuel the market growth during the forecast period. The adoption of automated and robotic systems in surgery is another driver estimated to contribute to the market growth. In a study conducted by the University of Michigan, School of Medicine, it was found that from 2012 to 2018 the use of robotic technology in general surgery increased from 1.8% to 15.1%.
Market players are leveraging this trend to introduce new products, expand their regional presence, and increase their market share. Bolder Surgical, partnered with Intuitive Surgical to provide an exclusive licensing agreement to its energy-based vessel sealing and tissue stapling technologies for use in the latter's robotic-assisted surgery solutions. In May 2021, Bowa Medical opened a new office in Cairo to control and support sales activities for Turkey, Iran, Pakistan, and the entire Middle East region.